Management of Suspected Cardiac Glycoside or Aconite Poisoning with Pericardial Effusion and Normal ECG
In a patient with hypotension, dyspnea, and pericardial effusion after herbal preparation ingestion—even with a normal ECG—immediately obtain serum potassium, digoxin level (if available), and echocardiography to assess for tamponade physiology, while preparing digoxin-Fab for empiric administration if cardiac glycoside poisoning is suspected based on the clinical syndrome.
Immediate Diagnostic Approach
The absence of ECG changes does not exclude life-threatening cardiac glycoside or aconite poisoning. This is a critical pitfall—both toxins can cause severe hemodynamic compromise before or without classic ECG findings.
Priority Laboratory Tests
- Serum potassium: Hyperkalemia is a hallmark of cardiac glycoside toxicity and correlates with severity 1
- Digoxin level: Essential for diagnosis, particularly in chronic toxicity which presents with nonspecific manifestations 2
- Basic metabolic panel: Assess renal function (affects drug clearance) and other electrolytes
- Troponin: Rule out myocardial injury
- Complete blood count: Baseline for potential interventions
Imaging Studies
- Echocardiography (urgent): Assess pericardial effusion size and for tamponade physiology (right atrial/ventricular collapse, respiratory variation in flow velocities) 3, 4
- Serial ECGs: Monitor for development of conduction abnormalities, though their absence doesn't rule out toxicity 1
Immediate Management Algorithm
Step 1: Stabilize Hemodynamics
For hypotension:
- Initiate IV fluid resuscitation cautiously
- If pericardial effusion shows tamponade physiology on echo, prepare for urgent pericardiocentesis 3, 4
- Avoid aggressive fluid loading if tamponade is present—definitive drainage is required
For dyspnea:
- Supplemental oxygen to maintain SpO2 >94%
- Position patient upright if tolerated (reduces pericardial pressure)
- Prepare for potential intubation if respiratory failure develops
Step 2: Toxin-Specific Antidote Decision
If cardiac glycoside poisoning suspected (oleander, foxglove, certain toad venoms in herbal preparations):
Administer digoxin-specific antibody fragments (digoxin-Fab) immediately if any of the following are present 1:
- Hyperkalemia (K+ >5.0 mEq/L in acute poisoning)
- Hemodynamic instability (hypotension, shock)
- Life-threatening arrhythmias (even if not yet present on ECG)
- Elevated digoxin level (though treatment should not be delayed waiting for results)
The 2023 AHA guidelines give this a Class I, Level B-NR recommendation for digoxin/digitoxin and Class 2a, Level C-LD for yellow oleander and Bufo toad venom 1. Response rates are 50-90% with dysrhythmia resolution in 30-45 minutes 1. Survival in cardiac arrest from digoxin poisoning treated with digoxin-Fab was 54% in observational studies 1.
If aconite poisoning suspected (Aconitum/Wolfsbane roots in traditional preparations):
No specific antidote exists 5, 6. Management is supportive with aggressive arrhythmia control:
- Continuous cardiac monitoring: Aconite causes ventricular arrhythmias (VT, VF, torsades) that correlate with plasma alkaloid levels 6
- Prepare antiarrhythmics: Have flecainide (first-line, 6/7 cases successful), amiodarone (11/20 cases), or mexiletine (3/3 cases) immediately available 6, 7
- Alert cardiopulmonary bypass team: Refractory ventricular arrhythmias may require ECMO or bypass as "time-buying" strategy (4/6 cases successful) 5, 6, 8
Step 3: Arrhythmia Management (If Develops)
For bradydysrhythmias (cardiac glycoside):
- Atropine 0.5-1 mg IV (may be reasonable, though variable efficacy) 1
- Avoid calcium in hyperkalemic patients with cardiac glycoside toxicity (controversial, may worsen toxicity)
- Transvenous pacing may be attempted but has 36% complication rate and may require higher-than-normal current 1
For ventricular arrhythmias:
- Cardiac glycoside: Lidocaine, phenytoin, or bretylium until digoxin-Fab takes effect 1
- Aconite: Flecainide or amiodarone preferred over lidocaine based on case series 6, 7
- Direct cardioversion: Often ineffective in aconite poisoning (5/30 cases) 6
- Prolonged CPR: Essential—extended resuscitation >200 minutes has been successful with hemoperfusion 8
Step 4: Enhanced Elimination
Cardiac glycoside:
- Do NOT use hemodialysis, hemofiltration, hemoperfusion, or plasmapheresis (Class 3: No Benefit recommendation) 1—digoxin has large volume of distribution and is not effectively removed 1
Aconite:
- Hemoperfusion may be considered in severe cases, though role not definitively established 5, 8
- One case report showed successful rescue with extended CPR combined with hemoperfusion 8
Critical Pitfalls to Avoid
Waiting for ECG changes: Both toxins can cause life-threatening hemodynamic collapse before classic ECG findings appear 2, 5
Delaying digoxin-Fab: If cardiac glycoside suspected, administer empirically—don't wait for confirmatory levels in unstable patients 1, 9
Assuming pericardial effusion is unrelated: The effusion may represent myopericarditis from the toxin or be coincidental, but tamponade physiology requires immediate drainage regardless of etiology 3, 4
Premature termination of resuscitation: Aconite-induced cardiac arrest may require prolonged CPR (>200 minutes documented) as alkaloids are metabolized 5, 8
Using standard cardioversion protocols: Aconite-induced VT/VF is often refractory to electrical cardioversion—prioritize antiarrhythmics and mechanical support 5, 6
Distinguishing Features
Cardiac glycoside toxicity typically presents with 1, 2:
- Gastrointestinal symptoms (nausea, vomiting)
- Confusion
- Hyperkalemia
- Bradyarrhythmias or AV blocks more common initially
Aconite toxicity typically presents with 5, 10:
- Paresthesias (face, perioral, extremities)
- Muscle weakness
- Rapid progression to ventricular tachyarrhythmias
- May occasionally present with bradyarrhythmias (atrial fibrillation with slow ventricular response) 10
The presence of neurological symptoms (paresthesias, numbness) strongly suggests aconite over cardiac glycoside poisoning 5.